December 19, 2016
Adocia/Lilly successfully complete insulin pump study
Adocia and Eli Lilly have completed an insulin pump study under the Adocia-Lilly partnership evaluating BioChaperone Lispro, an ultra-rapid formulation…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
December 19, 2016
Janssen asks FDA’s permission to treat adolescent plaque psoriasis patients with Solara
Janssen Biotech is looking to expand the usage of its prescription drug Stelara, as it has asked the U.S. Food…
December 16, 2016
Lilly/Incyte’s rheumatoid arthritis drug gets CHMP’s recommendation for EMA’s approval
Eli Lilly and Incyte Corporation have gotten positive opinion from European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
December 16, 2016
Novartis’s epilepsy drug gets CHMP’s positive opinion
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for…
December 16, 2016
FDA OK’s Cerenis’s CER-209 clinical trial for liver disease treatment
U.S. Food and Drug Administration (FDA) has given green light to Cerenis Therapeutics to proceed with CER-209 clinical trial.
December 16, 2016
RAC Approves Cellectis’s UCART123 Phase 1 study protocols in AML and BPDCN
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), has announced the National Institute…
December 15, 2016
Lilly/Boehringer Ingelheim: A long-acting basal insulin available in U.S.
Eli Lilly and Boehringer Ingelheim Pharmaceuticals have announced that Basaglar (insulin glargine injection 100 units/mL) is available by prescription in…
December 15, 2016
COMP gives positive opinion on Hansa Medical’s orphan drug
Hansa Medical, a biopharmaceutical company focusing on novel immunomodulatory enzymes, has announced that the Committee for Orphan Medicinal Products (COMP)…
December 15, 2016
Results of filgotinib Gilead’s study in Chron’s
Galapagos has tested its filgotinib – JAK1 inhibitor – in a phase 2 study, for the patients with Chron’s disease, and…
December 15, 2016
Bioven gets green light for NSC cancer drug testing patient enrolment
A cancer-focused drug-maker Bioven can now enrol patients in the USA in its international Phase III trial of EGF-PTI, in…